Darren R Churchward
Overview
Explore the profile of Darren R Churchward including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Highton P, March D, Churchward D, Grantham C, Young H, Graham-Brown M, et al.
Eur J Appl Physiol
. 2021 Dec;
122(3):599-609.
PMID: 34854982
Purpose: Patients receiving haemodialysis (HD) display elevated circulating microparticle (MP) concentration, tissue factor (TF) expression and markers of systemic inflammation, though regular intradialytic cycling (IDC) may have a therapeutic effect....
2.
March D, Hurt A, Grantham C, Churchward D, Young H, Highton P, et al.
Kidney Int Rep
. 2021 Jun;
6(6):1548-1557.
PMID: 34169195
Introduction: No formal cost-effectiveness analysis has been performed for programs of cycling exercise during dialysis (intradialytic cycling [IDC]). The objective of this analysis is to determine the effect of a...
3.
Hull K, Quann N, Glover S, Wimbury C, Churchward D, Pickering W, et al.
Hemodial Int
. 2021 Jun;
25(4):447-456.
PMID: 34133061
Introduction: End-stage kidney disease causes significant morbidity, mortality, and reduced quality of life. Despite improvements in conventional hemodialysis, these problems persist. In-center nocturnal hemodialysis (INHD) has been shown to be...
4.
Graham-Brown M, March D, Young R, Highton P, Young H, Churchward D, et al.
Kidney Int
. 2021 May;
99(6):1478-1486.
PMID: 34023029
Cardiovascular disease is the leading cause of death for patients receiving hemodialysis. Since exercise mitigates many risk factors which drive cardiovascular disease for these patients, we assessed effects of a...
5.
March D, Lai K, Neal T, Graham-Brown M, Highton P, Churchward D, et al.
Nephrol Dial Transplant
. 2021 May;
37(2):366-374.
PMID: 33983449
Background: Intradialytic cycling (IDC) may provide cardiovascular benefits to individuals receiving haemodialysis, but the exact mechanism behind these improvements remains unclear. The primary aim of this study was to investigate...
6.
Hull K, March D, Churchward D, Graham-Brown M, Burton J
Hemodial Int
. 2020 Mar;
24(2):133-147.
PMID: 32141181
Extended-hours hemodialysis is associated with improvements in quality of life (QoL) and mortality, but it may accelerate the loss of residual kidney function (RKF) and increase vascular access complications. Multiple...
7.
Young H, Jeurkar S, Churchward D, Dungey M, Stensel D, Bishop N, et al.
Clin Kidney J
. 2018 Dec;
11(6):832-840.
PMID: 30524718
Background: Research evidence outlines the benefits of intradialytic exercise (IDE), yet implementation into practice has been slow, ostensibly due to a lack of patient and staff engagement. The aim of...
8.
Young H, March D, Graham-Brown M, Jones A, Curtis F, Grantham C, et al.
Nephrol Dial Transplant
. 2018 Apr;
33(8):1436-1445.
PMID: 29608708
Background: Intradialytic cycling (IDC), delivered during haemodialysis (HD), has the potential to improve many health issues. This systematic review and meta-analysis examine the evidence on the effects of IDC on...
9.
Dungey M, Young H, Churchward D, Burton J, Smith A, Bishop N
Clin Kidney J
. 2017 Dec;
10(6):813-821.
PMID: 29225811
Background: Cardiovascular disease is the most common cause of mortality in haemodialysis (HD) patients and is highly predicted by markers of chronic inflammation. Regular exercise may have beneficial anti-inflammatory effects,...
10.
Graham-Brown M, Churchward D, Hull K, Preston R, Pickering W, Eborall H, et al.
Blood Purif
. 2017 Oct;
44(4):301-310.
PMID: 29084397
Evidence suggests extended-hours haemodialysis (HD) may improve cardiovascular, medical and quality-of-life outcomes. In-centre nocturnal haemodialysis (INHD) is an established but underutilized method of providing extended-hours treatment. This 6-month, non-randomized controlled...